Abiomed Inc financial data

Industry
Surgical & Medical Instruments & Apparatus
Location
22 Cherry Hill Dr, Danvers, MA
State of incorporation
DE
Fiscal year end
March 31
Latest financial report
10-Q - Q3 2022 - Nov 3, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 738 % +14%
Quick Ratio 70.7 % +1.12%
Debt-to-equity 10.9 % -8.5%
Return On Equity 17.8 % +57.2%
Return On Assets 16 % +58.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.1M shares -0.89%
Common Stock, Shares, Outstanding 45.2M shares -0.71%
Common Stock, Value, Issued 452K USD -0.66%
Weighted Average Number of Shares Outstanding, Basic 45.4M shares -0.14%
Weighted Average Number of Shares Outstanding, Diluted 45.7M shares -0.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.07B USD +10.3%
Research and Development Expense 167M USD +16.3%
Costs and Expenses 820M USD -0.95%
Operating Income (Loss) 254M USD +74.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 341M USD +60.8%
Income Tax Expense (Benefit) 74.4M USD +18.1%
Net Income (Loss) Attributable to Parent 267M USD +78.9%
Earnings Per Share, Basic 5.88 USD/shares +78.7%
Earnings Per Share, Diluted 5.84 USD/shares +80.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 182M USD -24.6%
Accounts Receivable, after Allowance for Credit Loss, Current 94.5M USD +5.48%
Inventory, Net 102M USD +18.9%
Assets, Current 1.06B USD +22%
Deferred Income Tax Assets, Net 18.9M USD +535%
Property, Plant and Equipment, Net 195M USD -1.03%
Operating Lease, Right-of-Use Asset 7.55M USD +48.1%
Goodwill 73M USD -6.66%
Other Assets, Noncurrent 193M USD +50.6%
Assets 1.7B USD +10.9%
Accounts Payable, Current 35.1M USD +27%
Employee-related Liabilities, Current 42.4M USD +18.1%
Accrued Liabilities, Current 69.4M USD +22.4%
Contract with Customer, Liability, Current 26M USD +7.83%
Liabilities, Current 134M USD +17.6%
Deferred Income Tax Liabilities, Net 689K USD -17.2%
Operating Lease, Liability, Noncurrent 6.62M USD +81%
Other Liabilities, Noncurrent 7.01M USD -15.5%
Liabilities 157M USD +7.76%
Accumulated Other Comprehensive Income (Loss), Net of Tax -46.6M USD -220%
Retained Earnings (Accumulated Deficit) 1.13B USD +31.1%
Stockholders' Equity Attributable to Parent 1.54B USD +11.2%
Liabilities and Equity 1.7B USD +10.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 68.1M USD +23%
Net Cash Provided by (Used in) Financing Activities -23.9M USD -220%
Net Cash Provided by (Used in) Investing Activities 8.11M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 48.4M shares +0.46%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 47.7M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 182M USD -24.6%
Deferred Tax Assets, Valuation Allowance 19.4M USD +23.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 75.1M USD +12.9%
Operating Lease, Liability 9.51M USD +55.4%
Depreciation 6.3M USD -4.55%
Payments to Acquire Property, Plant, and Equipment 6.78M USD -5.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 235M USD +65.5%
Lessee, Operating Lease, Liability, to be Paid 9.86M USD +53.2%
Property, Plant and Equipment, Gross 305M USD +4.88%
Operating Lease, Liability, Current 2.89M USD +17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.79M USD +98.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.01M USD +17.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Deferred Income Tax Expense (Benefit) -6.37M USD -201%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 352K USD +10%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.97M USD +69.4%
Deferred Tax Assets, Operating Loss Carryforwards 29.8M USD +6.84%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 982K USD +59.2%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%